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Abstract 
 
 The rising incidence of bacterial multidrug resistance has become a serious 
worldwide issue. The resistance-nodulation-cell division (RND)-type xenobiotic efflux 
system plays a major role in multidrug resistance of gram-negative bacteria. The only 
constitutively expressed RND system of Escherichia coli consists of the inner membrane 
transporter AcrB, the membrane fusion protein AcrA, and the outer membrane channel TolC. 
The latter two components are shared with another RND-type transporter AcrD, the 
expression of which is induced by environmental stimuli. In CHAPTER II of this study, I 
demonstrate how the RND-type ternary complexes, spanning the two membranes and the cell 
wall, are formed in vivo. Most foci of AcrB fused to green fluorescent protein (GFP) were 
fixed in the presence of TolC but showed lateral displacements when tolC was deleted. The 
fraction of fixed AcrB-GFP foci decreased with increasing levels of AcrD. I therefore propose 
that AcrD replaces AcrB in the complex with AcrA and TolC through a process I named 
“transporter exchange.” Moreover, transporter exchange was suppressed by AcrB-specific 
substrates, suggesting that the ternary complex is stabilized when it is in action. These results 
suggest that the assembly of the RND-type efflux system is dynamically regulated in response 
to external stimuli, shedding new light on bacterial adaptive antibiotic resistance.  
 Indole plays important roles in a wide variety of bacterial physiology such as 
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virulence, drug resistance, persister cell formation, motility, and quorum sensing, among other 
diverse physiological processes. The expression of the inner membrane transporter gene acrD 
is induced by the presence of high concentrations of indole via a two-component system 
(TCS) consisting of the sensor kinase BaeS and the response regulator BaeR. In CHAPTER 
III of this study, I first observed GFP-fused AcrD encoded by the chromosomal gene with the 
native promoter. Observation of AcrD-GFP foci required very high concentrations of indole. 
In contrast, AcrD-GFP foci were readily detected in a tolC-deletion derivative strain without 
exposing to exogenous indole. The deletion of the tryptophanase gene tnaA or the TCS genes 
baeSR abolished the constitutive expression of AcrD-GFP in the tolC-deleted strain. I next 
measured indole concentrations in the presence and absence of TolC. The intracellular 
concentration of indole in the tolC-deleted strain was about three times as high as that in the 
parental strain. In contrast, TolC had little effect on the extracellular concentration of indole. 
These results suggest that TolC is involved in indole efflux. Moreover, I examined whether 
the interaction between TolC and an inner membrane transporter is required for indole efflux. 
A mutant TolC protein, defective in coupling to the inner membrane transporter, decreased the 
level of accumulation of intracellular indole, though not as effectively as the wild-type protein. 
It was suggested that TolC provides a channel not only for drugs but also for indole to diffuse 
out of cell, and that E. coli monitors changes in the intracellular concentration of indole rather 
than extracellular one. 
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 Fluorescent proteins such as GFP have been used for labeling a cellular proteins. 
However, their large molecular weight of fluorescent proteins often interfere with the function 
of host protein, which would lead us to misdirected interpretations. In CHAPTER IV of this 
study, I applied florescent labeling methods other than fluorescent proteins to xenobiotic 
efflux and environment signaling systems. The fluorescein arsenical hairpin (FlAsH) 
specifically binds to a short peptide sequence of Cys-Cys-Pro-Gly-Cys-Cys (TC-tag), and it 
becomes fluorescent only when it binds covalently to a TC-tag. The TC-tagged outer 
membrane channel TolC of a part of the RND efflux system was labeled by FlAsH. This 
method resulted in the lateral localization of TolC without loss of their host functions. 
Moreover, I also used this FlAsH labeling method for the cytoplasmic signaling protein of 
Vibrio cholerae. I observed that the GFP-fused histidine kinase CheA1 of V. cholerae was 
localized to a cell pole and lateral region of the membrane with standing incubation or in the 
presence of sodium azide (NaN3) that inhibits cytochrome c oxydase, whereas the protein was 
diffused in cellular cytosol without such treatments. The localization pattern of TC-tagged 
CheA1 was consistent with those of the GFP fusions, arguing strongly that the behaviors of 
CheA1-GFP reflects the localization of the native protein. Next, I visualized the taurine/amino 
acid chemoreceptor Mlp37 of V. cholerae in vivo by using the fluorescently labeled L-serine 
5(6)-carboxyfluorescein ester (Ser-FAM). Upon treatment with Ser-FAM, fluorescent spots 
were detected at poles of cells expressing wild-type mlp37. Moreover, fluorescent spots of 
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Ser-FAM were decreased in the presence of non-fluorescent attractants serine and taurine, but 
not the weakest attractant L-glutamate, suggesting that the former attractants compete with 
Ser-FAM for binding to Mlp37. These results provide, for the first time, a tool to visualize 
direct ligand binding to a bacterial chemoreceptor in vivo and can also be applied to visualize 
signaling of TCSs and substrate transport in the xenobiotic efflux systems.   
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CHAPTER I 
General Introduction 
 
Bacterial antibiotic and multidrug resistance 
 Human has combated bacterial infections in this today. In 1928, Alexander Fleming 
incidentally discovered penicillin from a moldy petri dish and it had an ability to kill some 
bacteria. After 12 years, the other group at University of Oxford developed the 
mass-producing method of penicillin, and it was utilized as a therapeutic to treat patients of 
bacterial infection. For instance, in 1944, one of the deadly illnesses was tuberculosis which 
could be treated by streptomycin. Moreover, in 1950s, the various antibiotics including other 
than β-lactam as penicillin were discovered and used widely to pathogenic bacteria, which 
developed a chemotherapy (Davies & Davies, 2010). 
However, in late-1950s, antibiotics leaded antibiotic resistant bacteria, which 
synthesis the enzyme as β-lactamase that inactivate antibiotics, to spread to a medical front. 
Now, it has been known over 900 β-lactamase are divided into 4 classes (A-D) based on 
amino acid sequence (Fig. I-1) (Davies & Davies, 2010; Matagne et al., 1999). These genes 
are coded on bacterial chromosomes or plasmids, and are transferred by transposons and 
mobile genetic elements such as R plasmids (Adams et al., 2008). Serine-β-lactamases as 
penicillinase are found in Pseudomonas aeruginosa and Staphylococcus aureus, and 
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Metallo-β-lactamases are found in Escherichia coli, P. aeruginosa (Bush et al., 1995; Garau et 
al., 2004; Lambert, 2002). These are hydrolytic enzymes to the ester and amide bond of 
β-lactam which causes inactivation of antibiotic activity. Especially, Metallo-β-lactamases 
lead gram-negative bacteria to achieve the resistance to new-generated antibiotic 
cephalosporin recently (Walsh et al., 2005). The β-lactams interfere with synthesis of 
peptidoglycan layer in cell wall. The peptidoglycan plays an important role in the rigid 
structure of cell wall which is essential to cell growth, division, and retaining cell form of 
bacteria. The penicillin-binding proteins (PBPs) are major enzymes involved in the 
synthesizing cross-linking of peptidoglycan layers (Spratt, 1977). The active sites of PBPs are 
targeted in an attack of β-lactam antibiotics and formed highly stable PBP-β-lactam 
complexes, which lead to inactivate the synthesis of bacterial cell walls (Nguyen-Disteche et 
al., 1982). The β-lactamases modify PBPs to reduce the affinity for β-lactams, which results 
in the resistance to β-lactam antibiotics (Dzidic et al., 2008).  
The chloramphenicol and aminoglycosides interfere with protein synthesis by 
binding to each 50S and 30S ribosomal subunit of bacteria, respectively. An enzyme 
chloramphenicol transacetylase of gram-positive and -negative bacteria acetylates a hydroxyl 
group of chloramphenicol to prevent a binding of chloramphenicol to the 50S ribosomal 
subunit, which leads host strain to resist chloramphenicol (Morar & Wright, 2010). Also, the 
inactivating of aminoglycoside is caused by a phosphoryltransferase and adenylyltransferase 
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that modify the binding to the 30S ribosomal subunit, and its modification provides the 
resistance to aminoglycosides (Strateva & Yordanov, 2009).  
In 1980, the active efflux system for tetracycline in E. coli was originally reported 
(McMurry et al., 1980), and now has been discovered in any bacteria. The xenobiotic efflux 
systems (pumps) transport antibiotics and toxic compounds for bacteria out of cell and keep 
the low levels of intracellular concentration of those (Nikaido, 1998; Webber & Piddock, 
2003). Although some have drug-specificity, most of efflux systems are multidrug transporters 
that can transport various toxicants including drugs unrelated to structure and functional 
mechanism (Table. I-1). Thus, the multidrug efflux systems contribute pathogenic bacteria to 
resistance to a wide variety of antibiotics (Nikaido, 1998; Nikaido, 2000; Putman et al., 2000). 
The drug efflux transporters are classified into five categories: the major facilitator (MFS), 
small multidrug resistance (SMR), multidrug and toxic compound extrusion (MATE), 
ATP-binding cassette (ABC) and resistance-nodulation-cell division (RND) superfamilies (Li 
& Nikaido, 2009; Paulsen et al., 1996; Putman et al., 2000). A predominant cause of 
multidrug resistance of gram-negative bacteria is elevated expression of multidrug efflux 
transporters of the RND family (Nikaido, 1998). These systems comprise the inner membrane 
transporter (IMT), the outer membrane channel (OMC), and the membrane fusion protein 
(MFP) that is anchored to the inner membrane via a lipid moiety and bridges IMT and OMC 
(Nishino & Yamaguchi, 2001a; Paulsen et al., 1996). This transporter superfamily is 
4 
 
ubiquitous in nature, including higher animals and plants (Altmann et al., 2004). 
Use of many antibiotics over the years, the increasing use of antibiotics leading to the 
emergence of multidrug resistant bacteria is responsible for serious social problems. Our pace 
of the discovering new antibiotics has been slowed exponentially while the appearance of 
novel variants of multidrug resistant bacteria has increased. The methicillin was developed as 
a first designed β-lactam antibiotic to resist to a penicillinase-producing pathogenic bacteria 
such as S. aureus. After 3 years, however, the methicillin-resistance S. aureus (MRSA) which 
has resistance to many β-lactam antibiotics emerged and caused a serious bloodstream 
infection in the clinical front. Recently, it had enormous impacts on society that the spread of 
super multidrug resistant bacteria across the entire world was reported. This bacteria have the 
resistance to almost all β-lactam antibiotics, fluoroquinolone and aminoglycoside by New 
Delhi metallo-beta-lactamase (NDM-1) (Gelband & Laxminarayan, 2015). The potent drug 
resistant bacteria have threatened our public health, and also multidrug resistant bacteria have 
killed over 700,000 patients every year in the world (Shallcross et al., 2015). We have no 
perfect antibiotic that is effective in every bacteria without adverse effects, and also we are 
required a non-traditional proactive approach to multidrug resistant bacteria.  
 
Indole 
 Indole occurs widely throughout nature environment. Over the past 100 years, 
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bacteria produces indole have been found and used for bacterial taxonomy, identification and 
diagnostic test (Smith, 1897). Now at least 85 bacterial species including pathogenic 
Gram-negative and positive bacteria are known to produce a quantity of indole (Lee & Lee, 
2010). Indole is synthesized from amino acid tryptophan by tryptophanase, which is a 
cytoplasmic hydrolysis enzyme to reduce tryptophan to indole, pyruvate and ammonia. In 
Escherichia coli, these reactions are catalyzed by the tryptophanase TnaA (Stewart & 
Yanofsky, 1985) and many other proteins; tryptophan specific transporter TnaB, AroP, 
tryptophanase leader peptide TnaC, trp operon leader peptide TrpL and so on (Li & Young, 
2013). The indole biosynthesis is down regulated by environmental factors, such as a high 
concentration of glucose as carbon source (Wyeth, 1919), a high temperature (indole synthesis 
is stopped at 44.5°C) (Bueschkens & Stiles, 1984; Li et al., 2003), a low pH (TnaA is most 
induced at pH9.0) (Blankenhorn et al., 1999; Wyeth, 1919), and a cell density (Kobayashi et 
al., 2006). Biosynthetic indole has long been known to work as a chemorepellent of E. coli 
(Tso & Adler, 1974), and recently has also been learned as a chemical signaling molecule to 
an intra- and interspecies of bacteria which involve in the expression of many genes 
(Melander et al., 2014). The signaling of indole regulates the bacterial virulence (Hirakawa et 
al., 2009), drug resistance (Hirakawa et al., 2005), biofilm formation (Di Martino et al., 2002), 
genetic stability (Chant & Summers, 2007), persister cell formation (Vega et al., 2012), 
motility (Lee et al., 2007), and quorum sensing (Lee & Lee, 2010), among other diverse 
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physiological processes. It also has been known that indole is stable in E. coli cell because of 
no pathway of indole degradation and modification by enzymes (Chant & Summers, 2007; 
Lee & Lee, 2010). Moreover, the equilibrium of indole and its metabolism involve in an 
intestinal tract inflammation of mammalian (Bansal et al., 2010). Indole and derivations of 
tryptophan-metabolite play an important role in the regulation of broad-ranging physiology in 
bacteria and animals (Fig. I-2). 
 
Fluorescein arsenical hairpin binder (FlAsH) labeling 
 Fluorescence microscopy has been used for the study of protein localization and 
dynamics with a variety of chemical labeling methods. The discovery of green fluorescence 
protein (GFP) from the jellyfish Aequorea victoria (Shimomura et al., 1962) enable a 
fluorescent live-cell imaging using GFP fused host protein chimera. Moreover, GFP variants 
have been developed, such as enhanced GFP (EGFP) (McRae et al., 2005), superfolder GFP 
(sfGFP) (Pedelacq et al., 2006), and yellow fluorescence protein (YFP) (Ormo et al., 1996), 
and were utilized in various situations in cell biology. In spite of these benefits, fluorescence 
proteins were limited on use due to their large molecular weight. This molecular size 
interferes with the function, stability, and localization of their fused host protein (Swulius & 
Jensen, 2012). The fluorescein arsenical hairpin binder–ethanedithiol (FlAsH-EDT2) has been 
developed as an alternative approach for specific labeling in live-cell imaging (Griffin et al., 
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1998). FlAsH specifically binds to a short peptide sequence of Cys-Cys-Pro-Gly-Cys-Cys 
(TC-tag), and it forms intermolecular disulfide linker. FlAsH is complexed with EDT as a 
weakly fluorescence, and it becomes a fluorescence with binding to a TC-tag whose 
excitation and emission peaks are 508 and 528 nm, respectively. The equilibrium of 
FlAsH-EDT2 and FlAsH-TC depend on the concentration of EDT. In HeLa cell, FlAsH-TC is 
likely to be stable at ≤ 10 µM EDT which returned to a FlAsH-EDT2 as non-fluorescence state 
at ≥ 1 mM EDT (Griffin et al., 1998). FlAsH labeling technique is useful for live-cell imaging 
as an alternative to fluorescence proteins. 
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Fig. I-1. Increasing of number of identified β-lactamase. 
Number of β-lactamase, which inactivates β-lactam class of antibiotics, is on the increase. 
(cited from Davies & Davies, 2010) 
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Fig. I-2. Indole biosynthesis and signaling pathway in E. coli. 
This figure shows that the regulations of indole biosynthesis and indole-induced phenotype. 
Arrows and bar-head lines indicate up and down-regulation of gene expression or phenotype, 
respectively. 
 
 
  
10 
 
 
 
Table. I-1. Bacterial multidrug efflux systems and its substrates. 
This table shows that the typical multidrug efflux systems of clinical pathogenic bacteria and 
the toxic compounds are transported by those systems. 
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CHAPTER II 
Substrate-dependent dynamics of the multidrug efflux transporter AcrB of 
Escherichia coli 
 
Introduction 
 The increasing use of antibiotics has led to the emergence of multidrug resistant 
bacteria, a phenomenon that has serious consequences for public problems. A predominant 
cause of multidrug resistance of gram-negative bacteria is elevated expression of multidrug 
efflux transporters of the RND family (Nikaido, 1998) (Fig. II-1). These systems comprise an 
inner membrane transporter (IMT), an outer membrane channel (OMC), and a membrane 
fusion protein (MFP) that is anchored to the inner membrane via a lipid moiety and bridges 
IMT and OMC (Nishino & Yamaguchi, 2001a; Paulsen et al., 1996). This transporter 
superfamily is ubiquitous in nature and is found in prokaryotes and eukaryotes, including 
higher animals and plants (Altmann et al., 2004). The RND efflux systems of Escherichia coli 
and Pseudomonas aeruginosa have been extensively studied in terms of their biochemistry, 
molecular architecture, and patterns of gene expression (Stover et al., 2000). Among the five 
RND transporters of E. coli, only the AcrB-AcrA-TolC complex (hereafter referred to as 
AcrBA-TolC) is constitutively expressed (Sulavik et al., 2001) and plays a major role in its 
multidrug resistance (Nikaido, 1998; Okusu et al., 1996; Zgurskaya & Nikaido, 1999). The 
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structure-function relationship of the IMT AcrB is well studied. The proton-drug antiporter 
AcrB (Paulsen et al., 1996), which forms a homotrimer of 12-transmembrane (TM) subunits 
(Murakami et al., 2002), captures a wide variety of antibacterial compounds, including 
antibiotics, detergents and other amphiphilic agents, and directly transports these substrates 
out of the cell via TolC (Nikaido, 2000; Zgurskaya & Nikaido, 1999). TolC is also a 
homotrimeric protein consisting of an outer membrane domain folded into a 12-stranded 
β-barrel. It has a periplasmic extension (about 100 Å in length) with an α-helical coiled coil 
domain and a mixed α/β equatorial domain, which together form a hollow cylindrical 
structure that allows substrate to diffuse directly out of the cell (Koronakis et al., 2000). 
Whereas the TolC homotrimer has three-fold symmetry (Koronakis et al., 2000), the AcrB 
homotrimer is asymmetric, and each protomer plays a different role in substrate binding 
(Murakami et al., 2006). The functional association of AcrB with TolC is thought to require 
the MFP AcrA (Ma et al., 1993), the stoichiometry of which has not been unambiguously 
determined. However, a recent cryo-EM study suggests that AcrA forms a homohexamer (Du 
et al., 2014). 
 The transcription of various inducible xenobiotic efflux genes is regulated by 
two-component regulatory systems (TCSs) (Nishino & Yamaguchi, 2001b; Nishino & 
Yamaguchi, 2002), each typically consisting of a sensor kinase and a response regulator, 
which are widely distributed among prokaryotes and eukaryotes. The E. coli genome encodes 
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62 TCS proteins that mediate a variety of environmental responses (Kofoid & Parkinson, 
1988; West & Stock, 2001). Most RND genes encoding MFP/IMT pairs, including acrA/acrB, 
are located in tandem on the chromosome and form transcriptional units (Fig. II-2). Among all 
IMT genes, only the acrD gene stands alone. Its product, AcrD, is closely related to AcrB and 
also interacts with AcrA and TolC (Aires & Nikaido, 2005), the latter of which is encoded by 
a gene belonging to a separate operon (Fig. II-2). The AcrDA-TolC complex exports 
aminoglycosides and anionic β-lactams, such as carbenicillin and sulbenicillin, which are not 
transported by AcrB (Kobayashi et al., 2014; Nishino et al., 2003; Rosenberg et al., 2000). 
The expression of acrD is induced upon the addition of indole to culture media via the TCS 
consisting of the sensor kinase BaeS and the response regulator BaeR (Hirakawa et al., 2005; 
Nishino et al., 2005). 
 These properties raise an important question concerning assembly of the ternary 
complex. Do newly synthesized AcrD molecules assemble into a ternary AcrDA-TolC 
complex de novo, or do they replace AcrB subunits in the pre-existing AcrBA-TolC complex? 
It may be advantageous for bacteria to employ the latter mechanism, which we call 
“transporter exchange,” to remove harmful substrates promptly out of cells as quickly as 
possible. However, it has not been established how RND-type transporter complexes that 
bridge two separate membranes are assembled. These considerations, and the pioneering 
study on single molecule behaviors of bacterial membrane proteins (Leake et al., 2006), led us 
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to study the assembly and dynamics of the AcrB/D AcrA TolC protein complex in vivo. 
 I visualized AcrB in vivo using green fluorescent protein (GFP). Observations with 
total internal reflection fluorescence (TIRF) microscopy revealed that most fluorescent foci of 
AcrB-GFP were stationary and mobile in the presence and absence of TolC, respectively. I 
next examined the effect of AcrD on the dynamics of AcrB. The fraction of mobile AcrB-GFP 
foci increased with increasing levels of AcrD. I therefore propose that the AcrBA-TolC 
complex becomes unstable upon the induction of AcrD, which presumably replaces AcrB in 
the ternary complex. Moreover, such instability is suppressed upon the addition of 
AcrB-specific substrates. These results suggest that the assembly of the RND-type efflux 
system is a regulated dynamic process that provides bacteria with a highly flexible repertoire 
of survival strategies to cope with a wide spectrum of antibiotics. 
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Fig. II-1. Xenobiotic efflux protein families in E. coli. 
RND-type: Forms a tripartite complex. Captures a wide variety of toxic compounds and 
directly transports them out of cell via the outer membrane channel TolC. Plays a major role 
in multidrug resistance of gram-negative bacteria. MFS-type: The major membrane 
transporter family. A drug/proton antiporter with 12-14 transmembrane domains. Plays a 
major role in xenobiotic efflux by gram-positive bacteria. SMR-type: Related to the MFS-type 
but has 4 transmembrane domains. MATE-type: Related to the MFS-type but is driven by 
sodium ion. ABC-type: The ATP-binding-cassette-type with 4 transmembrane domains. 
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Results 
The AcrB-GFP trimer is stationary in the cytoplasmic membrane via its association with 
TolC in the outer membrane. 
I constructed a strain expressing green fluorescent protein (GFP)-fused AcrB from 
the chromosomal acrB locus (strain YKN12, a derivative of strain BW25113) (Datsenko & 
Wanner, 2000). The AcrB-GFP protein retained almost full activity as judged by the minimal 
inhibitory concentrations (MIC) of AcrB substrates (Fig. II-3B). To assess the effect of TolC 
on the AcrB-GFP dynamics within the cell membrane, I constructed a tolC-deleted derivative 
of YKN12 (strain YKN17). Immunoblotting with monoclonal anti-GFP antibody detected a 
band of AcrB-GFP without visible degradation products (Fig. II-4). The expression levels of 
the AcrB-GFP in a tolC-deleted strain was almost the same as that of the tolC+ strain (Fig. 
II-4). TIRF microscopic observations detected a clear difference in the lateral displacements 
of AcrB-GFP foci between strains YKN12 (tolC+) and YKN17 (∆tolC) (Fig. II-5A, B, D). Fig. 
II-5A and D show the x-y trajectories and the time lapse images of AcrB-GFP foci in these 
genetic backgrounds. AcrB-GFP movement (an AcrB subunit with 12 TMs has a molecular 
mass of 110 kDa) was analyzed by monitoring two-dimensional mean square displacements 
(MSD) of individual foci over time. In the presence of TolC, the calculated MSD values of all 
AcrB-GFP foci tested at time 330 ms were distributed below 0.5 × 10−2 µm2, with an average 
of 0.2 ± 0.1 (mean ± S.D.) × 10−2 µm2 (Fig. II-5B, 6A). In the absence of TolC, most 
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AcrB-GFP foci moved incessantly, and their MSD values were distributed over a wide range: 
2.3−10.7 × 10−2 µm2, with an average of 5.2 ± 2.2 (mean ± S.D.) × 10−2 µm2 (Fig. II-5B, 6A). 
I then fitted the data (i.e. the averaged MSD-∆t plots for stationary and mobile fractions of 
AcrB-GFP in strains YKN12 and YKN17) to linear regression models (Fig. II-6B). The 
diffusion coefficient (= D) values in the presence and the absence of TolC calculated from 
these fits are 6.8 ± 5.0 (mean ± S.D.) × 10−4 µm2 s−1 and 3.5 ± 1.8 × 10−2 µm2 s−1, respectively. 
When complemented with a plasmid encoding TolC, MSD values of AcrB-GFP foci and 
resistance to nalidixic acid returned to levels comparable to those of the parent strain (Fig. 
II-3B, 5B). AcrB-GFP foci in the tolC+ and the complemented strains showed about two 
orders of magnitude smaller D values (8.0 ± 4.0 × 10−4 µm2 s−1) than those in the ∆tolC strain. 
The former can be regarded as immobile within experimental errors. Based on these data, foci 
with MSDs at time 330 ms below and above 0.5 × 10−2 µm2 (marked with a dotted line in Fig. 
II-5B) will hereafter be designated as “stationary” and “mobile,” respectively. Accordingly, all 
the AcrB-GFP foci in the tolC+ background are stationary and those in the ∆tolC background 
are mobile, whereas 84% of those in the complemented strain are stationary (Fig. II-5C). In 
the tolC+ background, time-course analyses of the fluorescence emission from single 
stationary AcrB-GFP foci detected up to three-step photobleaching (Fig. II-7A). Fig. II-6B 
shows the power spectrum of one focus as the pairwise differences (Pairwise Difference 
Distribution Function, PDDF), which indicated the step size of single molecular GFP, with an 
18 
 
average of 680 ± 180 (mean ± S.D., arbitrary unit) under my experimental conditions (Fig. 
II-7B, C). The distribution of intensity at the first frame peaked at a value that is about three 
times the intensity of a single GFP estimated by photobleaching (Fig. II-7D). 
 
Visualization of TolC with a fluorescent reagent. 
I next examined whether stationary AcrB-GFP foci in the inner membrane indeed 
co-localize with TolC in the outer membrane. Substituting Cys for Ala-269 in an extracellular 
loop of TolC (11 residues in length; Fig. II-8A) did not affect the drug efflux activity as 
judged from MIC of nalidixic acid (Fig. II-3B). TolC-A269C was stained with the 
thiol-reactive fluorescent reagent Texas Red maleimide (TxRM) at low concentrations for a 
short period of time to minimize non-specific labeling of other Cys-containing proteins. TIRF 
microscopy detected foci of labeled TolC-A269C, some of which co-localized with AcrB-GFP 
(Fig. II-8B). No foci were observed in cells expressing wild-type TolC, demonstrating that 
non-specific labeling was negligible (Fig. II-8B). 
 
AcrB dissociates from the preformed complex with TolC and AcrA upon induction of 
AcrD. 
I was interested in determining whether the expression of AcrD, the closest homolog 
of AcrB, influences AcrB dynamics in the tolC+ strain. First, AcrD was expressed from an 
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arabinose-inducible plasmid. The fraction of mobile AcrB-GFP foci increased (from 8% to 
72%) with increasing concentrations (0−100 µM) of arabinose (Fig. II-9A, B) and increased 
(from 12% to 64%) over time (0−2 h) after the addition of 100 µM arabinose (Fig. II-9C, D). I 
suggest that the induction of AcrD facilitates dissociation of AcrB from the preformed 
complex with TolC and AcrA, presumably to from a new ternary complex (AcrDA-TolC). I 
then tested whether the dynamics of AcrB-GFP is influenced by the expression of AcrD from 
the native chromosomal gene. The expression of acrD was induced by the addition of indole 
or by overexpressing the TCS response regulator BaeR (Hirakawa et al., 2005; Nishino et al., 
2005). I next constructed a strain (named MBRT02) carrying a chromosomal gene encoding 
AcrD-GFP (the design is essentially the same as acrB-gfp in strain YKN12). In strain 
MBRT02, AcrD-GFP foci were observed when cells were exposed to indole or when BaeR 
was overexpressed from the plasmid (Fig. II-10A). The increased expression of AcrD-GFP 
induced by plasmid pBaeR was verified by immunoblotting with monoclonal anti-GFP 
antibody (Fig. II-10B). Consistent with that result, the fraction of mobile AcrB-GFP foci in 
YKN12 cells treated with indole (60%) was larger than that in cells not exposed to indole 
(4%) (Fig. II-11A, B). Taken together, these results demonstrate that transporter exchange 
occurs in the native setting. 
 
The AcrBA-TolC complex is stabilized by AcrB-specific substrates. 
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The findings just described raise the question of whether the induction of AcrD 
destabilizes the AcrBA-TolC complex while the latter complex is in the process of exporting 
its substrates. AcrBA-TolC, but not AcrDA-TolC, exports chloramphenicol and minocycline. 
When either of these substrates was added to the culture medium, the fraction of stationary 
AcrB-GFP foci became relatively insensitive to the expression of AcrD (32% without a 
substrate vs 84% with 4.9 µM chloramphenicol and 60% with 3.2 µM minocycline; Fig. 
II-11C, D). This was further examined under more physiological conditions: indole-induced 
expression of AcrD-GFP in MBRT02 cells. The functionality of the AcrD-GFP protein in 
these experiments was verified by checking MIC for an AcrD-specific substrate, carbenicillin 
(Fig. II-10C). The AcrB-specific substrate chloramphenicol decreased the fraction of 
stationary AcrD-GFP foci. I also examined whether the incorporation of IMT molecules into 
the ternary complex is affected by its substrate. The addition of the AcrD-specific substrate 
carbenicillin to cells expressing AcrD from the plasmid did not reduce the fraction of 
stationary AcrB-GFP (32% without a substrate vs 36% with carbenicillin; Fig. II-12). These 
results suggest that the AcrD-induced instability of the preformed AcrB-containing complex is 
suppressed when the preexisting complexes are transporting substrates, whereas the presence 
of a substrate of a second, newly synthesized transporter does not necessarily facilitate 
transporter exchange. 
  
21 
 
 
 
Fig. II-2. Characterization of AcrB-GFP and AcrD-GFP. 
(A) The loci of RND-component genes on the chromosome of E. coli str. K-12 substr. 
MG1655. (B) Construction of AcrB-GFP and AcrD-GFP. GFP was fused to the 
carboxy-terminus of AcrB or AcrD through a Gly3 linker. 
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Fig. II-3. Design and MIC test of AcrB-GFP. 
(A) Schematic illustration of AcrB-GFP in the cell surface of E. coli. For simplicity, AcrB is 
depicted to bind AcrA even in the absence of TolC, though it has not been experimentally 
tested. (B) Antibiotic susceptibility analysis. Wild-type AcrB and AcrB-GFP were expressed 
from the chromosomal genes of strains BW25113 and YKN12, respectively, while 
plasmid-encoded wild-type TolC (pKRB2100) and mutant TolC (A269C; pKRB2104) were 
expressed in strain YKN17 (∆tolC). Bold face represents the resistance indicative of the 
significant efflux activity. Abbreviations: CP, chloramphenicol; NA, nalidixic acid; ND, not 
determined (due to the plasmid-borne CP resistance).  
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Fig. II-4. Detection of AcrB-GFP using immunoblotting.  
AcrB-GFP (m/kDa = 140) was expressed in strains YKN12 (tolC+) (left lane) and YKN17 
(∆tolC) (middle lane). The wild-type strain BW25113 was used as a control (right lane). 
Whole cell lysates were subjected to Western blotting with monoclonal antibody raised 
against GFP and anti-mouse-IgG (Cell Signaling Technology) antibody labeled with 
horse-radish peroxidase. 
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Fig. II-5. AcrB-GFP dynamics in the cytoplasmic membrane. 
(A, B, C, D) x-y trajectories of AcrB-GFP in YKN12 (blue line) and YKN17 (red line) with 
the TIRF illumination (A) and time lapse images (D), MSD-∆t plots of AcrB-GFP foci (B) 
and fractions of mobile and stationary AcrB-GFP foci (C) in the presence or absence of TolC. 
Fluorescent foci were traced and their MSDs were calculated (n = 25). Closed symbols with 
error bars indicate averaged MSD values of all mobile (triangles) or stationary (circles) 
trajectories at each time with standard deviations. Dotted line in panel B indicates the 
boundary MSD value at time 330 ms to define mobile (red lines) and stationary foci (blue 
lines). 
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Fig. II-6. Tracking AcrB-GFP foci and calculation of their mean square displacements 
(MSD) in strains YKN12 and YKN17. 
(A) Distribution of MSD at time 330 ms of AcrB-GFP foci in the presence (left) or absence 
(right) of TolC. (n = 25). (B) The averaged MSD-∆t plots for stationary (left) and mobile 
(right) fractions of AcrB-GFP. These data were fitted with linear regressions. 
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Fig. II-7. Trimeric nature of fixed AcrB-GFP foci in the presence of TolC. 
(A) Three-step photobleaching of a single AcrB-GFP focus. Blue dots, the intensity of 
AcrB-GFP per frame; red line, output of the edge-detecting filtered intensity (window = 15); 
orange arrows, the positions of predicted steps with measured a step size respectively; and red 
numbers, the number of bleached GFP molecules. (B) Power spectra of the PDDF with arrows 
indicating step sizes of photobleaching trace. (C) Distribution of the detected step sizes of 
photobleaching (n = 20). Arrow indicates an average (mean ± S.D.) of the step sizes. (D) 
Distribution of the fluorescence intensity of single foci at the first frame obtained by 
subtracting the background value (n = 81). Arrow indicates an average (mean ± S.D.) of the 
foci intensity.  
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Fig. II-8. The co-localization of AcrB-GFP foci with fluorescently labeled TolC. 
(A) The crystal structure of the extracellular loop of the TolC trimer (PDB ID code: 2XMN). 
Purple balls indicate the positions of A269C. (B) Co-localization of AcrB and TolC. Images of 
AcrB-GFP (left) and TxRM-labeled TolC-A269C (middle) were merged (right). Arrow heads 
indicate TolC-A269C foci that did not co-localize with AcrB-GFP (top). Observation of 
TxRM-treated cells expressing AcrB-GFP and wild-type TolC. YKN17 cells transformed with 
plasmid pKRB2100 (wild-type TolC) were grown in the presence of arabinose and treated 
with 1 µM TxRM. Images of the same fields taken with emission filters for GFP (left) or 
TxRM (middle) were merged (right) (bottom). Scale bar, 1 µm. 
  
28 
 
 
 
Fig. II-9. The AcrD expression influenced the mobility of AcrB-GFP foci. 
Effect of plasmid-encoded AcrD induced with 0−100 µM arabinose for 2 h (n = 25) or with 
100 µM arabinose for 0−2 h (n = 25). (A, C) MSD-∆t plots of AcrB-GFP foci under various 
conditions. Dotted line indicates the boundary MSD value at time 330 ms to define mobile 
(red lines) and stationary foci (blue lines). (B, D) Fractions of stationary and mobile 
AcrB-GFP foci. 
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Fig. II-10. The expression and MIC test of AcrD-GFP. 
TIRF observation (A) and immunodetection (B) of AcrD-GFP (m/kDa = 140) in MBRT02 
cells. (C) Resistance of cells expressing AcrD (strain BW25113) or AcrD-GFP (strain 
MBRT02) to carbenicillin. Cells carrying the BaeR-expressing plasmid pBaeR or the vector 
pCA24N were cultured with 100 µM IPTG. 
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Fig. II-11. The effect of induction of the chromosomal acrD gene. 
(A, B) Effect of induction of the chromosomal acrD gene. The native acrD gene was induced 
with 4 mM indole for 2 h (n = 25). Cells were also treated with 1% dimethyl sulfoxide as a 
negative control. (C, D) Effects of the AcrB-specific substrates chloramphenicol (CP, 4.9 or 
3.2 µM) and minocycline (MINO, 3.2 µM) on MSDs of AcrB-GFP under AcrD-inducing 
conditions. The plasmid-borne acrD gene was induced with 100 µM arabinose for 2 h (n = 
25). MSD-∆t plots (A, C) and fractions of stationary and mobile of AcrB-GFP foci (B, D). 
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Fig. II-12. Effect of an AcrD-specific substrate on transporter exchange. 
Carbenicillin (CBPC) was added to the culture for 1.5 h after acrD was induced with 100 µM 
arabinose. Cells were further incubated for 0.5 h. (A) MSD-∆t plots of AcrB-GFP with (left) 
or without (right) 6.25 µM CBPC. (B) The fractions of stationary and mobile AcrB-GFP foci 
(n = 25) with or without CBPC. 
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Discussion 
In this study, I examined dynamics and assembly of AcrB, the major RND-type 
xenobiotic efflux transporter in the inner membrane (IMT) of E. coli. With TIRF microscopy, 
I found that most foci of GFP-fused AcrB were stationary in the presence of TolC, whereas 
they showed lateral diffusion in the membrane of the ∆tolC strain. The co-localization of 
AcrB-GFP with TolC was detected by chemically labeling TolC. I also found that the 
induction of AcrD destabilizes the AcrBA-TolC complex, presumably resulting in the 
exchange of AcrB-GFP in the preexisting complex with newly synthesized AcrD. The fraction 
of mobile AcrB-GFP foci increased with increasing expression levels of AcrD. Furthermore, 
the AcrD-induced instability of the AcrBA-TolC complex was suppressed by AcrB-specific 
substrates, suggesting that the assembly of the RND-type efflux system is a regulated 
dynamic process. 
The D value of moving AcrB-GFP obtained in our TIRF microscopic analyses (3.5 ± 
1.8 × 10−2 µm2 s−1) is roughly one order of magnitude smaller than that of the E. coli serine 
chemoreceptor Tsr fused to the fluorescent protein Venus (4.0 ± 0.1 × 10−1 µm2 s−1) (Oh et al., 
2014). The difference in the D value between these proteins is reasonable considering that in 
the number of TMs: AcrB is a homotrimer of 12-TM subunits and Tsr is a homodimer of 
2-TM subunits (or exists as a trimer of dimer). The fact that AcrB-GFP foci are stationary in 
the presence of TolC is consistent with the structural feature of TolC. Because the periplasmic 
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extension of TolC penetrates the peptidoglycan layer, a rigid three-dimensional mesh-like 
supramolecule, the lateral diffusion of TolC molecules must be very restricted. Thus, the 
diffusion of AcrB, once assembled into the complex with TolC, must also be limited. 
I detected three-step photobleaching of stationary AcrB-GFP foci. I also detected 
double-sized steps, indicating that two GFP molecules were bleached simultaneously or 
successively. These results demonstrate that at least a majority of TolC-associated AcrB 
molecules form trimers. The broad distribution of MSD value in the absence of TolC might 
reflect interactions with other membrane proteins or a mixed population of AcrB-GFP 
monomers and oligomers. 
Leake et al (2006) reported that TIRF illumination visualizes approximately one sixth 
of the surface of a cell within 100 nm of a coverslip (Leake et al., 2006). In the tolC+ strain, I 
detected an average of 7.5 ± 1.6 (mean ± S.D., n = 50) stationary foci of AcrB-GFP per cell in 
the TIRF illumination field. I therefore estimate that there are 45 ± 9.6 foci of AcrB-GFP 
trimers per cell, which corresponds to 135 ± 28.8 molecules of AcrB-GFP per cell if a 
majority of foci represented trimers. This estimation is consistent with estimated values the 
literature (< 500 molecules) (Tikhonova & Zgurskaya, 2004). Because the number of TolC 
molecules per cell is nearly three times higher than that of AcrB molecules (Tikhonova & 
Zgurskaya, 2004), and because the level of TolC expressed from the plasmid-borne gene must 
be higher than from the chromosomal gene, it is likely that not all labeled TolC co-localized 
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with AcrB-GFP and that TolC is in excess. 
Expression of the acrAB operon is regulated by AcrR repressor and transcriptional 
activators such as MarR and SoxS (Ma et al., 1996; Perez et al., 2012; Watanabe & Doukyu, 
2012). However, the operon is known to be “constitutively” expressed under laboratory 
conditions (Sulavik et al., 2001), whereas genes encoding other IMTs, including AcrD, of 
RND-type xenobiotic efflux systems are expressed at very low levels in E. coli and are 
induced by environmental stimuli such as indole-induced and other stresses on the cell 
envelope (Hirakawa et al., 2005; Raffa & Raivio, 2002). Because AcrD shares TolC and AcrA 
with AcrB, and assuming that the induction signal for AcrD (indole) does not significantly 
affect the cellular amounts of AcrB, AcrA and TolC, it was reasonable to ask whether AcrD 
can replace AcrB in the preformed AcrBA-TolC complex. Indeed, the expression of AcrD 
either from the chromosomal gene with the native promoter (induced by indole) or the 
promoter-less gene under the control of the araBAD promoter (induced by arabinose) 
increased lateral diffusion of AcrB-GFP, which was otherwise stationary in complex with 
TolC and AcrA. This AcrD-induced instability of the AcrBA-TolC complex, which may result 
in transporter exchange, would be part of adaptive drug resistance, an important bacterial 
responses to harmful substances. It should also be noted that transporter exchange may occur 
between different molecules of the same IMT: for instance, the AcrBA-TolC complex may 
undergo assembly and disassembly with some frequency. Thus, an RND-type xenobiotic 
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efflux complex is not rigid or fixed but allows association and dissociation of its components. 
The next obvious question is whether the AcrD-induced instability of the 
AcrBA-TolC complex can be regulated. Our results indicate that there is some level of 
regulation: the AcrBA-TolC complex was stabilized by the AcrB-specific substrates. Of the 
two substrates tested, minocycline showed weaker effects, likely because it has a lower 
affinity for AcrB. Minocycline might also be sequestered because it chelates divalent metal 
ions in the medium (Leyden, 1985). These results suggest that the AcrBA-TolC complex is 
stabilized by substrate binding, slowing the exchange of AcrB with AcrD. The stabilization of 
a ternary complex when it is in action should be advantageous for bacterial survival. In 
particular, AcrB can transport the widest range of substrates among all xenobiotic transporters 
(Nishino & Yamaguchi, 2001a), including the bacterium’s own metabolites or their 
derivatives such as fatty acids and bile salts (Ma et al., 1995). Interference with the activity of 
AcrB when cells are exposed to its substrate(s) would presumably have adverse effects on 
viability (Murakami & Yamaguchi, 2003). The AcrD-specific substrate, however, had little 
effect on the stability of the ternary complex. Thus, the presence of a substrate for a 
non-associated IMT may not necessarily accelerate destabilization of preexisting ternary 
complexes. Alternatively, a free IMT might not bind its substrate. A thermodynamics study 
suggests that, in the absence of substrate, AcrB forms a symmetric trimer, and that forced 
substrate binding to one protomer induces and stabilizes an asymmetric form of the AcrB 
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trimer (Yao et al., 2010). In vivo, an IMT might bind its substrate to become an asymmetric 
trimer only when it is in the ternary complex. The resulting asymmetric IMT trimer might 
stabilize the IMT-MFP-OMC ternary complex, making it resistant to transporter exchange. 
Alternatively, the AcrBA-TolC complex might be stabilized by some endogenous substrate(s). 
The AcrBA-TolC complex might also be stabilized by some endogenous substrate(s) (Fig. 
II-13). 
 
In this chapter, the full data were published in Scientific Reports (Yamamoto et al., 
2016). 
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Fig. II-13. The transporter exchange model.  
The pre-formed AcrB-AcrA-TolC complex becomes instable upon the induction of AcrD, 
which presumably result in the exchanges of AcrB with AcrD to form a new AcrDA-TolC 
complex (left). The pre-formed ternary complex can be stabilized by its substrates (right). 
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CHAPTER III 
Accumulation of indole in the cell induces the multidrug efflux transporter 
gene acrD 
 
Introduction  
The RND-type multidrug efflux transporter AcrD is closely related to AcrB, and 
shares MFP AcrA and OMC TolC with AcrB (Aires & Nikaido, 2005). The AcrDA-TolC 
complex exports aminoglycosides and anionic β-lactams, such as carbenicillin and 
sulbenicillin, which are not transported by AcrB (Kobayashi et al., 2014; Nishino et al., 2003; 
Rosenberg et al., 2000). The acrD is expressed at very low levels in E. coli under the standard 
laboratory conditions and is induced upon the addition of indole to culture media via the TCS 
consisting of the sensor kinase BaeS and the response regulator BaeR (Hirakawa et al., 2005; 
Nishino et al., 2005). Indole is synthesized from tryptophan by a variety of bacterial species, 
including E. coli, and hence is present throughout natural environments (Lee & Lee, 2010). 
 This laboratory constructed a strain expressing GFP-fused AcrD from the 
chromosome of strain BW25113. In the resulting strain, fluorescence foci of AcrD-GFP were 
observed when cultured in the presence, but not in the absence, of 4 mM indole. Although the 
concentrations required for induction are consistent with the literature (Hirakawa et al., 2005), 
4 mM seems too high compared to physiological concentrations of indole (0.6 – 1.2 mM; Li 
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& Young, 2013) which bacteria would encounter in the intestine (Knarreborg et al., 2002). 
Therefore, the real trigger or signal that a bacterium senses to induce AcrD must not be 
extracellular indole itself, but rather something resulting from high extracellular indole 
concentrations. Here, based on the following lines of evidence, I propose that it is intracellular 
indole that triggers the acrD expression. First, I observed fluorescent foci of AcrD-GFP in a 
tolC-deletion derivative strain, but not in the parental strain, without exposing to indole or any 
exogenous agents. The effect of the tolC deletion was reversed by the expression of wild-type 
TolC or mutant TolC defective in drug efflux. Second, the deletion of the tryptophanase gene 
tnaA or the TCS genes baeSR abolished the constitutive expression of AcrD-GFP in the 
tolC-deleted strain. Third, the direct measurements of indole concentration revealed that the 
intracellular concentration of indole in the tolC-deleted strain was higher than that in the tolC+ 
strain. 
 
Results 
The deletion of tolC influences the acrD expression 
 I examined whether the expression of acrD is induced by the addition of indole as 
reported previously (Hirakawa et al., 2005). In strain MBRT02 which carries the 
chromosomal acrD-gfp gene (for detail, see CHAPTER II of this study), TIRFM observation 
detected AcrD-GFP foci when cells were treated with 4 mM indole for 2 h, but scarcely did 
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without indole (Fig. III-1A). Interestingly, in the tolC-deleted derivative strain MBRT05, 
AcrD-GFP foci were detected without treating with indole (Fig. III-1B, left). When 
complemented with a plasmid encoding TolC (pKRB2109), AcrD-GFP foci were not 
observed without indole (Fig. III-1B, middle). Furthermore, I constructed a tnaA-deleted 
derivative from MBRT05. In the resulting tnaA tolC double-deletion strain encoding 
AcrD-GFP (named YKN51), AcrD-GFP foci were not observed without indole despite the 
absence of TolC (Fig. III-1B, right). These results suggest that the deletion of tolC results in 
the constitutive expression of acrD. 
 I next measured the expression of AcrD-GFP quantitatively using a microplate reader. 
The fluorescence intensity of ∆tolC cells carrying the plasmid encoding TolC was decreased 
about 23%, compared to those with the empty vector (Fig. III-2A). The ∆tolC ∆tnaA double 
mutant showed decreased fluorescence intensity, which returned to the level of the parent 
strain by introducing a tnaA-expressing plasmid (Fig. III-2A, B). Moreover, the fluorescence 
intensity was substantially reduced by the deletion of baeSR, whose products mediate indole 
responses (Fig. III-2B). These results are consistent with the TIRFM observation of 
AcrD-GFP described above. Presumably, the deletion of tolC might causes the accumulation 
of indole, or some other factor, in the cytosol or some deformation in the cell surface, either of 
which might trigger the acrD expression by activating the BaeSR system. 
The outer membrane channel TolC works as a part of RND efflux system with inner 
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membrane transporter. The constitutively expressed transporter AcrB and its paralog AcrF of 
E. coli are considered to play a central role in the efflux of intracellular xenobiotics. The 
deletion of acrB and acrF, however, had little effect on the AcrD-GFP expression (Fig. 
III-2B). I then asked whether TolC can complement the expression of AcrD-GFP without an 
interaction with transporters. Based on the literature (Tamura et al., 2005), I constructed a 
plasmid encoding mutant TolC with the substitution of a Gly×4 linker for residues 
Q142-A150 in the loop between helices H3 and H4 (named TolC∆loop), which is defective in 
drug efflux as judged from chloramphenicol resistance (Fig. III-2C). I also constructed a 
plasmid encoding TolC and TolC∆loop fused to mCherry (a red fluorescent protein). These 
fusion proteins were detected by immunoblotting with anti-RFP antibody without visible 
degradation products and apparently localized to the cell surface as judged from observation 
with epi illumination (Fig. III-2D, E). The expression of either mCherry-fused TolC or 
TolC∆loop AcrD-GFP in the tolC-deleted strain decreased the expression of AcrD-GFP (Fig. 
III-2A, C), suggesting that even mutant TolC defective in coupling to an inner membrane 
transporter can suppress the induction of acrD. 
 
Measuring the amount of intracellular indole 
I then examined whether indole is indeed accumulated in a ∆tolC cell using Kovac’s 
reagent. About 33.5% difference was detected for the amount of intracellular indole between 
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in the tolC+ (0.881 ± 0.199 × 106 molecule/cell) and the tolC-deleted (2.629 ± 0.150 × 106 
molecule/cell) strain. It was estimated that the concentration of intracellular indole in a cell at 
332.74 ± 75.27 µM and 992.45 ± 56.56 µM, respectively (Fig. III-3, right). In contrast, the 
difference of the amount of indole that was transported to the extracellular space was no more 
than about 5.6% (129.476 ± 1.381 × 106 molecule/cell in the tolC+ vs 122.637 ± 0.987 × 106 
molecule/cell in the ∆tolC). These values correspond to 167.76 ± 1.79 µM and 158.9 ± 1.28 
µM, respectively. In the tolC-deleted strain, the total amount of indole was about 4.1% 
smaller than that in the tolC+ strain. Moreover, when complemented with the TolC-encoding 
plasmid, the amount and concentration of indole returned to levels comparable to those of the 
parent strain. With TolC∆loop, the complementation level of any indole test was lower than 
those with wild-type TolC. These results suggest that the lack of TolC renders indole to be 
accumulated in the cell, which may induces the expression of acrD. 
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Fig. III-1. Observation of AcrD-GFP under various conditions. 
Fluorescent imaging of AcrD-GFP from chromosomal gene with TIRFM. (A) In the presence 
of tolC strain MBRT02, cells were treated with or without 4 mM indole for 2 h. (B) 
Observation of AcrD-GFP in a tolC-deleted strain MBRT05 (left) and in a tolC and 
tnaA-deleted strain YKN51 (right). Cells carrying the TolC expressing plasmid pKRB2100 
were cultured with 100 µM arabinose for 2 h (middle). 
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Fig. III-2. The deletion of tolC induced the chromosome-encoded acrD-gfp. 
(A, B) The relative of AcrD-GFP intensity in the various backgrounds using microplate reader. 
Each bar represents the mean ± standard deviation of data (n = 3). (A) Cells carrying the 
wild-type TolC, TolC∆loop mutant, mCherry fused TolC or TnaA-expressing plasmid or the 
vector pBAD24 were cultured with 100 μM arabinose. (C) Antibiotic susceptibility analysis. 
The tolC+ (WT) and ∆tolC cells expressing AcrD-GFP from the chromosomal genes. The 
plasmid-encoded wild-type TolC and its variants were expressed in the ∆tolC strain. (D, E) 
The immunodetection (D) and epi fluorescent imaging (E) of mCherry fused TolC and 
TolC∆loop (m/kDa = 80) in the ∆tolC strain. 
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Fig. III-3. The measuring intra- and extracellular indole. 
Cells carrying the wild-type TolC or TolC∆loop mutant-expressing plasmid or the vector 
pBAD24 were cultured with 100 μM arabinose. The amount of indole are shown as the 
accumulation of intracellular indole (intracellular), the excretion of indole to supernatant 
(extracellular), and the total amount of indole that have been produced by a cell (total) per cell 
(left). The closed circle indicates the concentration of intracellular indole (right). Each bar 
represents the mean ± standard deviation of data (n = 3).  
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Discussion 
In this chapter, I examined whether the outer membrane channel TolC of RND-type 
transports indole to out of cells. With fluorescence microscopic observation, I found that a 
deletion of tolC induced the chromosome-encoded acrD-gfp without exogenous agents as 
indole. Because this induction was inhibited by the deficiency of tryptophanase TnaA which 
synthesizes indole from tryptophan, I suspected an increasing concentration of intracellular 
indole in the absence of tolC. Hirakawa et al reported that the expression of acrD is induced 
by the addition of indole to culture media via the TCS consisting of the sensor kinase BaeS 
and the response regulator BaeR (Hirakawa et al., 2005). Indeed the lacking BaeSR regulation 
system suppressed the expression of acrD-gfp in the tolC-deleted background, which was 
complemented with plasmid encoding BaeSR (Yamazaki, unpublished). These results 
reinforced that the intracellular indole induces the acrD-gfp expression via BaeSR. 
In Kawamura-Sato et al, they proposed that AcrEF-TolC of RND-system involves in 
indole efflux based on there was about 1.7 times difference in the intracellular indole 
concentration between the acrEF mutant and wild-type strain (Kawamura-Sato et al., 1999). 
On the other hand, Pinero-Fernandez’s group argued using by measuring concentration of 
supernatant indole that the excretion of indole is a free diffusion without support of 
RND-efflux system or other protein to transport indole (Pinero-Fernandez et al., 2011). 
Although, it is not clear from this literature whether RND-system affects the concentration of 
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intracellular indole. Then, I found that there was about 3 times difference in the amount of 
intracellular indole per cell between in the presence (330 µM) and the absence of TolC (990 
µM). I thought that the reason why I had a difference of the estimated indole concentration 
with Kawamura-Sato et al is that they did not subtract a background quantity of the 
tnaA-deleted strain which produces no indole from an actual measurement (see materials and 
methods). In contrast, based on the amount of extracellular indole, it appears that TolC had 
little effect on indole excretion. The final extracellular indole concentration is dependent on 
the excretion of indole which is biosynthesized in early exponential phase (Kobayashi et al., 
2006). Thus, these integrated extracellular indole concentration may counteract the effect of 
indole efflux by TolC. A high pH condition increases the concentration of extracellular indole 
as a result of inducing the expression of tnaA (Blankenhorn et al., 1999; Wyeth, 1919). It also 
has been reported that TolC may play a physiological role in pH homeostasis through an 
interaction with the proton motive force in a multidrug efflux transporter (Deininger et al., 
2011). In the tolC-deleted strain, the total amount of indole which was produced by one cell 
was smaller than that in the tolC+ strain. I suspected that this result reflects the difference in 
the amount of indole due to a change in the intracellular pH homeostasis with the loss of 
proton transfer by RND efflux systems. 
 The deletion of major RND-type inner membrane transporter AcrB and its paralog 
AcrF did not affect the AcrD-GFP expression, which raise the next obvious question whether 
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the interaction with TolC and inner membrane transporter involves in indole efflux. In fact, 
TolC∆loop mutant, which has no drug efflux activity, decreased the concentration of 
intracellular indole. These results suggested that TolC can transport indole to out of cell 
without an interaction with inner membrane transporter. TolC is the pore-like outer membrane 
channel whose entrance conformation is changed the closing-state into the opening-state by 
interaction with inner membrane transporter. However, non-interaction TolC state has been 
unclear in vivo. It is possible that indole directly passes through TolC whichever its state is 
switched. 
 The high concentration of extracellular indole (about 2 mM) induces the expression 
of multidrug transporter genes including acrD (Hirakawa et al., 2005). However, E. coli 
produces up to about 0.6 mM indole, which mainly depends on the concentration of 
tryptophan, in a rich medium including 0.5 mM tryptophan. The concentration of indole 
reaches about 4.5 mM at 24 h if the 5 mM tryptophan is ever added to the culture medium (Li 
& Young, 2013). In the intestine of pig, the maximum indole concentration has been estimated 
to be 0.12 mM with about <0.5-0.7 mM (in the small intestine) and <0.1 mM (in the large 
intestine) tryptophan (Knarreborg et al., 2002). Thus, it is unthinkable that the extracellular 
indole reaches up to 2 mM under normal physiological conditions. It was suggested that E. 
coli senses the change of indole concentration in not the supernatant but the cytosol. In my 
additional considerations, the possibility still remains that E. coli senses not only the indole 
49 
 
but also the envelope stress of its accumulation. An envelope stress by indole affects the 
expression of various gene including multidrug efflux gene acrD via TCS BaeSR and CpxAR 
in E. coli (Hirakawa et al., 2005; Raffa & Raivio, 2002). In fact, it have been known that a 
high concentration of indole, which is toxic to E. coli, influences the persister cell formation 
(Vega et al., 2012). The major envelope sensor CpxA might sense injurious stimuli of inner 
membrane that was induced by intracellular indole, and it transmits this signal to the cognate 
response regulator CpxR or BaeR as a cross-talk. In the complex web of indole signal 
pathway, my results suggested that indole-induced gene expressions are caused by 
intracellular indole signals (Fig. III-4). 
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Fig. III-4. Proposed model of the gene expression by indole stimuli. 
In this study, I proposed that the expression of acrD is caused by the accumulation of 
intracellular indole via two-component regulatory system. Arrows indicate transport or 
stimulus or induction. 
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CHAPTER IV 
Methods for fluorometric imaging of outer and inner membrane proteins 
 
Introduction 
 In cell biology, the fluorescent protein labeling techniques often are used for 
visualization of the organisms and protein complexes. These techniques can analyze 
localizations and dynamic of structures which are not detected in a live cell by the optical 
microscopy unmounting the fluorometric imaging systems. Moreover the fluorescent tag 
imaging do not require an immobilization like an immunostaining and the transmission or 
scanning electron microscopy methods. Although fluorescent protein fusion is critically useful, 
it potentially could cause artificial distributions. The fluorescent proteins have large molecular 
mass (e.g. GFP; 27 kDa) and some tags potentially dimerize, which inhibit the functions of 
fused protein (Swulius & Jensen, 2012). I also have tested the imaging using other florescent 
labeling methods.  
 The outer membrane channel TolC was stained by fluorescent reagent Texas Red 
maleimide in CHAPTER II. Because the N-terminus and C-terminus ends of TolC, which 
interact with membrane fusion protein AcrA, locate in periplasmic space, it is difficult to fuse 
TolC and fluorescent protein. I therefore tagged TolC with a tetracysteine (TC)-tag at its 
C-termini and examined their localization by staining with fluorescein arsenical hairpin 
binder–ethanedithiol (FlAsH-EDT2) (Griffin et al., 1998; Hoffmann et al., 2010). FlAsH 
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specifically binds to a short peptide sequence of Cys-Cys-Pro-Gly-Cys-Cys (TC-tag), and it 
forms intermolecular disulfide linker (about 1.5 kDa). I also observed TC-tag fused histidine 
kinase CheA1 for the chemotactic signal transduction in Vibrio cholerae under aerobic and 
anaerobic conditions. 
The amino acid chemoreceptor Mlp37 of V. cholerae was found to serve for taurine 
as well as serine, arginine and other amino acids. I determined the crystal structures of the 
ligand binding domain of Mlp37 in complex with L-serine and taurine. The structure revealed 
the slightly open conformation of the ligand binding domain in the serine complex. These 
findings led me to visualize Mlp37 in vivo with a fluorescently labeled amino acid: L-serine 
5(6)-carboxyfluorescein ester (Ser-FAM), in which carboxyfluorescein is linked to the 
hydroxyl group of L-serine through an ester bond. 
 
Results 
Labeling of outer membrane channel TolC and CheA1 with FlAsH. 
 I constructed the plasmids, which are arabinose inducible vector, encoding 
C-terminal TC-tag fusion of TolC (TolC-TC) and wild-type TolC. In a tolC-deleted strain 
JW5503, fluorescence microscopic observation detected their localized foci of lateral regions 
of cell membrane expressing TolC-TC with any concentration of arabinose by fluorescent 
reagent FlAsH (Fig. IV-1A top). Huge foci were detected to a cell pole with 30 and 100 µM 
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arabinose (Fig. IV-1A bottom). These foci might be aggregated TolC trimers. However no foci 
were observed in cells expressing wild-type tolC, demonstrating that non-specific labeling 
was ignorable. The TolC-TC protein retained almost full activity as judged by the minimal 
inhibitory concentrations (MIC) of nalidixic acid (Fig. IV-1B). 
 Next I observed the localization of GFP-fused histidine kinase CheA1 of V. cholerae 
with or without sodium azide (NaN3) that inhibits cytochrome c oxydase. Cells expressing 
CheA1-GFP at late logarithmic phase were incubated. The localization of CheA1-GFP foci 
were dispersed throughout the cell. NaN3 dramatically altered the localization of CheA1-GFP 
foci, which showed the localization to a cell pole and lateral region of the membrane (Fig. 
IV-2 top). Moreover I also constructed TC-tag-fused CheA1 and observed their localization in 
the same as above conditions. These localization patterns were similar to those of CheA1-GFP 
(Fig. IV-2 bottom). These localization results of CheA1 including other chemotaxis-related 
proteins were published in Molecular Microbiology (Hiremath et al., 2015).  
 
Observation of Mlp37 with a fluorescently labeled serine. 
In mlp24 and mlp37-double deleted strain Vmlp201, fluorescent spots were detected 
at poles of cells expressing wild-type mlp37 from plasmid (pMlp37) with Ser-FAM (Fig. 
IV-3C) treating, but not those carrying empty vector (Fig. IV-3A). I also examined foci of 
Ser-FAM under the other ligands. A 10-fold molar excess of L-serine or taurine was added 
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when cells were exposed to Ser-FAM, which decreased the occurrence of polar foci. By 
contrast, adding L-glutamate, one of the weakest attractants, did not affect Ser-FAM labeling 
(Fig. IV-3A). These results suggest that the former attractants and Ser-FAM compete for 
binding to Mlp37. Moreover I constructed a plasmid encoding Mlp37-TagRFP (named 
pKRB116). When cells expressing the TagRFP-fused Mlp37 were treated Ser-FAM, 
florescence microscopy detected foci of Ser-FAM, which co-localized with Mlp37-TagRFP 
(Fig. IV-3B). These results not only confirm the mechanism of ligand recognition by Mlp37, 
but also provide, for the first time, a tool to visualize ligand binding to a bacterial 
chemoreceptor in vivo. 
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Fig. IV-1. FlAsH stained images of cells expressing TolC-TC. 
Cells carrying the TolC-TC expressing plasmid pKRB2107 or the TolC expressing plasmid 
pKRB2100 in a tolC-deleted strain JW5503 were cultured with 10−100 µM arabinose for 2 h. 
(A) Fluorescent imaging of TolC-TC and wild-type TolC with FlAsH. (B) Antibiotic 
susceptibility analysis. Bold face represents the resistance indicative of the significant efflux 
activity. 
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Fig. IV-2. Effect of NaN3 on the localization of CheA1. 
Fluorescent imaging of CheA1-GFP and FlAsH labeled CheA1-TC in O395N1 strain. Cells 
carrying the CheA1-GFP expressing plasmid pAH191 or the CheA1-TC expressing plasmid 
pKRB101 with or without NaN3. 
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Fig. IV-3. Fluorescent imaging of Mlp37 with Ser-FAM. 
(A) Competitive labeling of Mlp37 with carboxyfluorescein-labeled L-serine (Ser-FAM). 
Vmlp201 (∆mlp24 ∆mlp37) cells carrying the pAH901 vector (none) or pMlp37 (Mlp37) 
were incubated in TMN buffer containing 100 µM Ser-FAM supplemented with none (+ 
none), 1 mM serine (+ Ser), 1 mM taurine (+ taurine), or 1 mM glutamate (+ Glu). (B) 
Co-localization of Ser-FAM with Mlp37. Vmlp201 cells expressing Mlp37-TagRFP were 
treated with Ser-FAM: left, Mlp37-TagRFP; middle, Ser-FAM; right, merge. (C) Ser-FAM 
structural formula. 
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Discussion 
 In CHAPTER II, labeling of TolC was performed with substituting Cys for Ala-269 
and staining by the thiol-reactive fluorescent reagent Texas Red maleimide (TxRM). However 
the high background fluorescence was shown, which was caused by non-specific labeling of 
other Cys-containing proteins, in spite of staining at low concentrations for a short period of 
time. In this chapter, I explored the methods of TolC staining with higher specificity and no 
effect on the efflux activity for in vivo live-cell imaging. FlAsH-EDT2 is formed 
non-fluorescent complex with ethanedithiol (EDT). When it binds to TC-tag amino acids 
sequence, these FlAsH-TC complex becomes fluorescent. This property achieves a low 
background fluorescence. TolC-TC fusion protein retained a full function of drug efflux, and 
their foci localized to lateral region of the cell membrane. However some large foci were 
detected to a cell pole in an over expression of TolC-TC (30 and 100 µM arabinose), which 
may be caused by the disulfide bonds with each other’s Cys of TC-tags. The localization of 
GFP-fused CheA1 of V. cholerae depends on aerobic condition in the culture. These behavior 
of CheA1 are consistent with those of the GFP fusion and TC-tag fusion. The effects of 
aerobic conditions suggest that the characteristic localization of System I components must be 
triggered neither by growth retardation nor by mechanical stimuli but by impaired energy 
metabolism (Hiremath et al., 2015). The FlAsH labeling is helpful as a in vivo live-cell 
imaging method with low background and low harmful influence to its function alternative to 
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fluorescent proteins.  
 The observation of the chemoreceptor is usually performed with direct visualizing 
using fluorescent protein or specific reagent in vivo. In this study, I observed a fluorescein 
linked ligand binding to the chemoreceptor. Serine is one of the strongest attractants of the 
chemoreceptor Mlp37 of V. cholerae. Mlp37 was labeled with Ser-FAM, which can be 
outcompeted by excess amounts of serine or taurine, validates the structural information. It 
also provides a cell biological tool to study bacterial chemotaxis, which has not been available 
for study of E. coli or any other bacterium until now. 
 In this chapter, the full data about localization of CheA1 and Mlp37 were published 
in in Molecular Microbiology (Hiremath et al., 2015), and were accepted to Scientific Reports 
(Nishiyama et al., 2016).  
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CHAPTER V 
Conclusions 
 
The RND-type efflux system of bacteria plays a major role in multidrug resistance, 
and it has been studied particularly for its structure and function such as transporter’s 
substrates. However, it has been unclear how RND-ternary complex was assembled and the 
regulations of the expression of RND components genes under the physiological condition. In 
this thesis, I aimed to understand how the newly synthesized molecules assemble into ternary 
complex and how indole as a cellular signal molecule acts as expression of acrD gene. 
 In CHAPTER II of this study, I focused on the subcellular dynamics of inner 
membrane transporter AcrB, and tried visualization of the construction processes of the efflux 
protein complex. TIRFM observation detected that the fraction of moving AcrB-GFP foci 
increased with increasing levels of the closely related transporter AcrD (named “transporter 
exchange”). Moreover, I demonstrated that this exchange was suppressed by AcrB-specific 
substrates. I propose that newly synthesized transporter molecules can destabilize preexisting 
RND-type efflux complexes to facilitate transporter exchange. This exchange is suppressed by 
substrates of the transporter that is already in the complex. This mechanism may enable a 
rapid adaptive resistance to a newly encountered toxic compound. Increasing the instability of 
the RND-type efflux complex could facilitate the development of effective cocktails of 
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antibiotics that are substrates for different drug efflux systems to overcome drug resistance by 
gram-negative bacteria. In CHAPTER III of this study, I focused on indole efflux by 
RND-systems and the expression of indole-induced gene acrD. First, I focused on the data of 
lacking of TolC induced the expression of acrD. Measuring the intracellular concentration of 
indole, I demonstrated that TolC involves in indole efflux. Second, TolC mutant whose drug 
efflux activity was inactivated which decreased the concentration of intracellular indole. This 
results suggested that TolC is able to transport indole to extracellular environment without an 
interaction with inner membrane transporter. I proposed that the expression of acrD is caused 
by the accumulation of intracellular indole via two-component regulatory system BaeSR, and 
also E. coli senses not only direct stimulus of indole but also the envelope stress by indole 
accumulation. 
 In CHAPTER IV of this study, I examined the cellular protein imaging using FlAsH 
labeling methods and fluorescent amino acid serine alternative to fluorescent protein. 
TC-tag-fused proteins were labeled and localized without loss of original functions. This 
method established high specificity labeling and low background fluorescence in live cell. 
The method using fluorescent serine (Ser-FAM) is novel approach of visualizing 
chemoreceptor directly.  
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CHAPTER VI 
Materials and Methods 
 
Strains and plasmids 
Bacterial strains and plasmids used in this study are described in Table VI-1, 2. The plasmid 
vector pTrcHisB (Invitrogen) carries the trc promoter, lacIq and bla. The pTrcHisB-derived 
plasmid pDS1050 encodes Gly3−linked−GFP (Hiremath et al., 2015). The plasmid vectors 
pBAD24 and pBAD33 carry bla and cat, respectively, in addition to the araBAD promoter 
and araC, which encodes the regulator of the araBAD promoter (Guzman et al., 1995). The 
plasmid pTWV228 is a pBR322-based vector carry bla and lac promoter (Takara Bio). The 
primers used for the plasmid and the strain constructions in this study are described in Table 
VI-3. 
 
Construction of plasmids encoding wild-type or GFP-fused IMT.  
The acrB- or acrD-coding region was amplified using PCR to introduce NheI and 
BglII sites at their 5ʹ and 3ʹ ends, respectively. The resulting fragment was cloned between the 
NheI and BglII sites of the vector pDS1050 to yield plasmids encoding AcrB-GFP 
(pKRB2000) or AcrD-GFP (pKRB2010). For tight regulation of acrD expression, plasmid 
pBAD24 was used as a vector to clone a PCR-amplified coding region with NcoI and HindIII 
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sites at its 5ʹ and 3ʹ ends, respectively, to yield pKRB2050. The 3.3-kb MluI-HindIII fragment 
of pKRB2050 was cloned between the corresponding sites of plasmid pBAD33 to yield 
pKRB2053. 
 
Construction of plasmids encoding wild-type or mutant TolC.  
A tolC-expressing plasmid was constructed by cloning a PCR-amplified fragment 
containing the 5ʹ-untranslated and the coding regions of tolC between the SacI and HindIII 
sites of the vector pBAD33 to yield plasmid pKRB2100 encoding wild-type TolC. The 
upstream primer used was designed to cover 28 bases just upstream of the deduced 
Shine-Dalgarno sequence of chromosomal tolC: 
5ʹ−CGAGCTCTTGATCGCGCTAAATACTGCTTCACCAC−3ʹ (the double underlined 
sequence represents the SacI recognition site). And also a tolC-expressing plasmid was 
constructed by a PCR-amplified fragment was cloned between the NheI and HindIII sites of 
vector pBAD24 to yield plasmid pKRB2109 encoding wild-type TolC. A derivative of 
pKRB2100 encoding TolC-A269C (pKRB2104) was constructed using the QuickChange II 
one-day site-directed mutagenesis method (Stratagene) with Pyrobest DNA Polymerase 
(Takara Bio) and DpnI (New England Biolabs). A derivative of pKRB2109 and pRE1300 
(Tamai, 2013) encoding TolC∆loop (pKRB2123) and mCherry-fused TolC∆loop (pKRB2122) 
was constructed by TolC substituting Gly×4 linker for Q142-A150 in the loop between H3 
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and H4 helix. A tetracysteine (TC; Cys-Cys-Pro-Gly-Cys-Cys) tagged tolC-expressing 
plasmid was constructed by inserting TC sequence in between A269 and A270 (pKRB2107). 
 
Construction of plasmid encoding TnaA.  
The tnaA-expressing plasmid was constructed by a PCR-amplified fragment was 
cloned between the NheI and HindIII sites of vector pBAD24 to yield plasmid pKRB803 
encoding TnaA. 
 
Construction of plasmid encoding TC-tagged CheA1. 
For TC-tagged CheA1, its gene was amplified using primers containing a sequence 
for a 3 × Gly linker followed by a C-terminal TC-tag and were cloned into the plasmid vector 
pTrcHisB (pKRB101). 
 
Construction of plasmid encoding TagRFP fused Mlp37. 
For construction of a plasmid encoding Mlp37-TagRFP, the TagRFP coding region 
was amplified by standard PCR using plasmid pTagRFP-C (Evrogen) as a template with 
primers designed for cloning and introducing a 3 × Gly linker at the N-terminus of TagRFP. 
The amplified fragment was cloned into plasmid pTWV228 (Takara Bio) to yield pKRB112 
expressing free TagRFP with the linker. The mlp37 gene was amplified using pMlp37 as a 
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template and was cloned into plasmid pKRB112 to yield pKRB116 expressing the 
Mlp37-TagRFP fusion. 
 
Construction of strains YKN12 and MBRT02 with chromosome-encoded AcrB-GFP and 
AcrD-GFP, respectively.  
Strains were constructed using a λ Red recombination system with plasmid pKD46 
encoding the Red recombinase (Datsenko & Wanner, 2000) and positive selection for the loss 
of tetracycline resistance (Bochner et al., 1980). To replace the stop codon of acrB or acrD on 
the chromosome of the standard strain BW25113 with the selectable tetracycline-resistance 
gene (tetRA), I designed primers with 40-nucleotide arms and generated fragments using PCR 
with plasmid pKRB2000 or pKRB2010 as the template. After recombination, selection and 
isolation, tetRA was replaced by a Gly3-GFP-encoding fragment with 40-nucleotide arms at 
their 5ʹ and 3ʹ ends. Tetracycline-sensitive clones were selected using tetracycline-sensitive 
medium (1% Bacto Tryptone, 0.5% Yeast Extract, 1% NaCl, 0.2% glucose, 50 µg mL−1 
chlortetracycline hydrochloride, 1% NaH2PO4-H2O, 12 µg mL
−1 fusaric acid, and 0.1 mM 
zinc chloride). 
 
Construction of the tolC, tnaA and acrF-deletion strain. 
These genes deletion strains were introduced using P1 transduction with strains 
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JW5503 (Baba et al., 2006) JW3686 and JW3234 as donors, and YKN12, MBRT05k− and 
MBRT04k− as recipients, respectively. After the selection on LB medium containing 
kanamycin and sodium citrate, transductants were purified twice. These strains were named 
YKN17, YKN51 and YKN58, respectively. 
 
Removing kanamycin cassette. 
The plasmid pCP20 encoding FLP recombinase is a temperature-sensitive replication 
(Datsenko & Wanner, 2000). Constructed kanamycin-resistant mutants were transformed with 
pCP20 to yield ampicillin-resistance were selected at 30°C for 18 h. Transformants were 
colony-purified at 43°C for 16 h in a damp. Then, these were tested for loss of an 
ampicillin-resistance and kanamycin-resistance. 
 
Construction of the baeSR-deletion strain YKN37. 
Strain was constructed using a λ Red recombination system with plasmid pKD46 
encoding the Red recombinase (Datsenko & Wanner, 2000). To replace the target gene on the 
chromosome of the strain MBRT05 with the tetracycline-resistance gene (tetRA) including 
40-nucleotide arms. 
 
Analyses of single molecule behaviors using TIRF microscopy.  
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Cells were grown in TG medium [1% Bacto Tryptone, 0.5% NaCl and 0.5% (w/v) 
glycerol] supplemented with appropriate antibiotics with shaking at 30°C for 16 h. The 
overnight cultures were diluted 100-fold into fresh TG medium and incubation was continued 
for 4 h. Cells were harvested and washed twice with MLM buffer (10 mM potassium 
phosphate buffer pH7.0, 0.1 mM potassium EDTA pH7.0, 10 mM sodium lactate pH7.0 and 
0.01 mM L-methionine). 
The expression of AcrD-GFP or AcrD form the chromosomal gene was induced by 
the addition of indole or introduction of a plasmid encoding BaeR (pCA24N-baeR, pBaeR) 
(Kitagawa et al., 2005). Cells were grown in TG medium supplemented with appropriate 
antibiotics with shaking at 30°C for 16 h. The culture was diluted 100-fold into fresh TG 
medium and further cultured for 2 h, and then 1% DMSO (negative control), 4 mM indole or 
100 µM isopropylthiogalactoside (IPTG) were added to the culture, which was then incubated 
for 2 h. Cells were harvested and washed twice with MLM buffer. 
Experiments to test the stability of the ternary complex were conducted using 
plasmid pKRB2050 carrying the wild-type acrD coding region downstream of the 
arabinose-inducible araBAD promoter. YKN12 cells (acrB-gfp) transformed with pKRB2050 
were grown for 16 h with shaking at 30°C in TG medium supplemented with ampicillin. 
Cultures were diluted 100-fold into fresh TG medium and cultured for another 2 h. Arabinose 
at appropriate concentrations was then added to the culture and incubation continued for 
68 
 
another 2 h. The tolC complementation test was performed with induction of the 
plasmid-borne tolC at 100 µM arabinose. Cells (∆tolC) transformed by plasmid pKRB2100 
were harvested and washed twice with MLM buffer. When necessary, antibiotics were added 
at appropriate concentrations 1.5 h after the addition of arabinose. 
Cells were spotted onto a poly-L-lysine-coated coverslip, washed with MLM buffer 
and were observed using objective-type TIRF microscopy (Sako et al., 2000; Tokunaga et al., 
1997) with an Olympus IX71 equipped with a 100× oil-immersion objective lens, lasers and a 
dichroic mirror (Semrock Di01-R488-561). GFP was visualized using a Cobolt Blues 50 mW 
laser (Cobolt 0473-04-01-0050-300) and emission filter (Semrock FF01-520/35-25). TxRM 
was visualized using a Cobolt Jive 50 mW laser (Cobolt 0561-04-01-0050-300) and emission 
filter (Semrock FF01-593/40-25). Images were recorded with 33 ms exposure using an 
EMCCD camera (Andor iXon DU-897). All of the image analysis was performed with the 
ImageJ ver. 1.48 software (NIH) and custom LabVIEW programs. For tracking single foci, 
each images were filtered with the rolling ball algorithm (Rolling Ball Radius: 12 pixels) to 
subtract the background intensity. I defined a 7 × 7 pixel (350 × 350 nm) region of interest 
(ROI) centered on a focus in the first frame of the images with the threshold appropriately 
adjusted (Leake et al., 2006). Individual foci were tracked through >30 frames. The mean 
square displacements (MSDs) were calculated as described in the literature (Kusumi et al., 
1993). The diffusion coefficients (=D) were calculated from the values of averaged MSD-∆t 
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plots with linear regressions fitting of the first ten points. 
 
Estimation of the number of AcrB-GFP molecules per focus using three-step 
photobleaching. 
The analysis was carried out essentially as described in the literature (Leake et al., 
2006). In images recorded with the exposure times of 33 ms for 10 s using TIRF microscopy, 
fluorescent intensity per frame of a ROI centered at a fluorescent focus was monitored over 
time. The edge-detecting method of non-linear filtering (window = 15) was used to identify 
photobleaching steps in the time-course of fluorescence intensity of AcrB-GFP foci (Leake et 
al., 2006; Smith, 1998). 
 
Fluorescent labeling of TolC-A269C.  
YKN17 cells (∆tolC) transformed with plasmid pKRB2100 encoding TolC-A269C 
or the vector pBAD33 (a negative control) were grown in TG medium at 30°C for 16 h. The 
culture was diluted 100-fold into fresh TG medium and cultured for 2 h, and then 10 µM 
arabinose were added to the culture, which was further incubated for 2 h. Washed cells were 
treated with 1 µM TxRM (Texas Red C2 Maleimide, Molecular Probes) at room temperature 
for 5 s and then quickly washed twice with MLM before observation by TIRF microscopy. 
Images were averaged (10 frames) using the ImageJ ver. 1.48 software (NIH) with custom 
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macros. 
 
Antibiotic susceptibility analysis.  
Minimum inhibitory concentrations (MICs) were determined on YT agar plates 
(0.8% Bacto Tryptone, 0.5% Yeast Extract, 0.5% NaCl, 1.5% Bacto Agar) containing 
chloramphenicol, nalidixic acid, or carbenicillin at various concentrations. When necessary, 
100 µM arabinose or 100 µM IPTG were added. YT agar plates were made using 2-fold serial 
dilutions techniques (Nishino & Yamaguchi, 2001a). Bacteria were grown in YT medium at 
37°C for 16 h. The culture was diluted 100-fold into fresh YT medium supplemented with 100 
µM arabinose or 100 µM IPTG, if necessary, and cultured further. YT agar plates with 
antibiotics and appropriate inducers, if necessary, were inoculated with aliquots of cell 
suspension (2.5 µL each containing 105 cells) and then incubated at 37°C for 18 h. 
 
Immunoblotting.  
Cells were grown in TG medium supplemented with appropriate antibiotics with 
shaking at 30°C for 16 h. The overnight culture was diluted 100-fold into fresh TG medium 
and further cultured for 4 h. Cells were harvested, washed twice with MLM buffer, 
resuspended in MLM with 8.3% 2-mercaptoethanol and 16.7% SDS, and subjected to 
SDS-PAGE followed by immunoblotting using a monoclonal anti-GFP antibody (Nacalai 
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Tesque) and anti-TagRFP antibody (Evrogen). Immune complexes were detected using 
horseradish-peroxidase (HRP)-labeled anti-mouse IgG (KPL) and the Immobilon Western 
Chemiluminescent HRP Substrate system (Merck Millipore). 
 
FlAsH labeling of TC-tagged proteins. 
FlAsH staining was carried out according to the original protocols (Griffin et al., 
1998; Hoffmann et al., 2010) with modifications. Cells were grown at 30˚C in TG medium 
with appropriate antibiotic. Overnight cultures were diluted 50-fold into fresh TG medium 
and incubated for 4 h at 30˚C (TolC) or 37˚C (CheA1). Cells were harvested by centrifugation 
at room temperature and resuspended in 100 µl of MLM or TMN buffer [50 mM Tris-HCl 
(pH-7.4), 5 mM glucose, 100 mM NaCl] in E. coli or V. chorea strain, respectively. 
Ethanedithiol (EDT, Nacalai Tesque), tris-(2-carboxyethyl) phosphine (TCEP, Nacalai 
Tesque), and LumioTM Green (Invitrogen) were added to final concentrations of 0.25 mM, 1 
mM and 0.5% (v/v), respectively. Cells were then incubated for 1 h at 30ºC, washed twice 
with MLM or TMN buffer and subjected to fluorescence microscope observations. NaN3 
(final concentration: 0.2%) was added to TMN buffer, if necessary. MAS-coated glass slides 
(Matsunami Glass Ind., Osaka) were used to immobilize cells. All images were recorded and 
processed by using a cooled charge-coupled-device camera ORCA-ERII (Hamamatsu 
Photonics) and the software Metamorph ver. 7.6 (Universal Imaging). 
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Ser-FAM labeling and the observation of TagRFP-fused Mlp37. 
Cells carrying the pAH901 (Nishiyama et al., 2012) vector pMlp37 were grown at 
30˚C in TG medium supplemented with 50 µg/ml ampicillin. Overnight cultures were diluted 
50-fold into fresh TG medium and incubated for 4 h at 37˚C. Cells were harvested by 
centrifugation at room temperature and resuspended in 100 µl of TMN buffer and 100 µM 
Ser-FAM [L-serine 5(6)-carboxyfluorescein ester] (Eurofins Genomics Inc., Tokyo) was 
added. If necessary, non-labeled L-serine or taurine (final concentration: 1 mM) was added to 
TMN buffer. Cells were then incubated for 30 min at 37ºC, and washed once with TMN 
buffer. An aliquot of the cell suspension was spotted onto a MAS-coated glass slide 
(Matsunami Glass Inc., Osaka). Cells were then observed under a fluorescence microscope 
(Olympus IX71) equipped with a 100× oil-immersion objective lens. TagRFP-fused Mlp37 
was visualized using fluorescence mirror units U-MWIG3 (Olympus). All images were 
recorded and processed by using a cooled charge-coupled-device camera ORCA-ERII 
(Hamamatsu Photonics) and the software Metamorph ver. 7.6 (Universal Imaging). 
 
Observation of AcrD-GFP from chromosomal gene using TIRF microscopy.  
Strain MBRT02, MBRT05 and YKN51 cells were grown in TG medium with 
shaking at 30°C for 16 h. The overnight cultures were diluted 50-fold into fresh TG medium 
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and incubation was continued for 4 h. When acrD-gfp was expressed by indole, the culture 
was diluted 50-fold into fresh TG medium and further cultured for 2 h, and then 1% DMSO 
(negative control), 4 mM indole were added to the culture, which was then incubated for 2 h. 
The tolC and tnaA complementation tests were performed with induction of the 
plasmid-borne tolC (pKRB2109) and tnaA (pKRB803) at 100 µM arabinose. Cells were 
harvested and washed twice with MLM buffer. Cells were spotted onto a poly-L-lysine-coated 
coverslip, washed with MLM buffer and were observed using TIRF microscopy with an 
Olympus IX71 equipped with a 100× oil-immersion objective lens, lasers and a dichroic 
mirror (Semrock Di01-R488-561). AcrD-GFP was visualized using a Cobolt Blues 50 mW 
laser (Cobolt 0473-04-01-0050-300) and emission filter (Semrock FF01-520/35-25). Images 
were recorded with 33 ms exposure using an EMCCD camera (Andor iXon DU-897). All of 
the image analysis was performed with the ImageJ ver. 1.48 software (NIH). 
 
Measuring intensity of AcrD-GFP 
Cells were grown in TG medium with shaking at 30°C for 16 h. The overnight 
cultures were diluted 50-fold into fresh TG medium and incubation was continued for 4 h. 
The tolC and tnaA complementation tests were performed with induction of the 
plasmid-borne tolC (wild-type and its variants) and tnaA at 100 µM arabinose for 4 h. Cells 
were harvested and resuspended in 200 µl of MLM buffer. Cell samples were applied into 
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individual wells of a 96-well microplate (IWAKI 3860-096) and their intensity were measured 
at 490 nm excitation and 530 nm emission using microplate reader (CORONA MTP-880). 
These data were plotted on a chart based on the intensity in MBRT05 as a positive control. 
 
Measuring indole production. 
 Measuring indole concentration was carried out according to the original protocols 
(Kawamura-Sato et al., 1999; Li & Young, 2013; Pinero-Fernandez et al., 2011) with 
modifications. Cells were grown in TG medium with supplemented 50 µg/ml ampicillin with 
shaking at 30°C for 16 h. The overnight cultures were diluted 50-fold into fresh 15 ml of TG 
medium and incubation was continued for 4 h. The tolC complementation test was performed 
with induction of the plasmid-borne tolC (wild-type and its variants) at 100 µM arabinose for 
4 h. Cells were harvested, and its supernatants were treated with a sterilizing filter (Merck 
Millipore Millex-GP 0.22 μm PES 33mm RS). For measuring the concentration of 
extracellular indole, the 500 µl of sterilized supernatants were added 300 µl of Kovac’s 
reagent (Merck Millipore) and were incubated for 5 min at room temperature. Then, for 
measuring the concentration of intracellular indole, the cell pellets were dissolved by 500 µl 
of kovac’s reagent and were incubated for 5 min at room temperature. A 50 µl portion of 
upper surface of reacted sample was diluted in 950 µl of 1-butanol. The absorbance at 540 nm 
was measured by the spectrophotometer (GE Healthcare), and indole concentration was 
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calculated using a standard curve. 
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Table. VI-1. Bacterial strains used in this study. 
 
Relevant characteristics Parent Source or reference 
E. coli strains 
   
BW25113 wild type W1485 
Datsenko & Wanner, 
2000 
JW0451 ∆acrB::kan BW25113 Baba et al., 2006 
JW3234 ∆acrF::kan BW25113 Baba et al., 2006 
JW3686 ∆tnaA::kan BW25113 Baba et al., 2006 
JW5503 ∆tolC::kan BW25113 Baba et al., 2006 
YKN12 acrB-gfp BW25113 Yamamoto et al., 2016 
YKN17 acrB-gfp ∆tolC::kan BW25113 Yamamoto et al., 2016 
MBRT02 acrD-gfp BW25113 Yamamoto et al., 2016 
MBRT04 acrD-gfp ∆acrB::kan BW25113 Tamai, 2013 
MBRT04k− acrD-gfp ∆acrB BW25113 This study 
MBRT05 acrD-gfp ∆tolC::kan BW25113 Tamai, 2013 
MBRT05k− acrD-gfp ∆tolC BW25113 This study 
YKN37 acrD-gfp ∆tolC::kan ∆baeSR::tetRA BW25113 This study 
YKN51 acrD-gfp ∆tolC ∆tnaA::kan BW25113 This study 
YKN58 acrD-gfp ∆acrB ∆acrF::kan BW25113 This study 
V. cholera strains    
O395N1 chemotaxis wild type O395 Hiremath et al., 2015 
Vmlp201 ∆mlp24 ∆mlp37 O395N1 Nishiyama et al., 2016 
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Table. VI-2. Vectors and plasmids used in this study. 
 
Relevant characteristics Parent Source or reference 
pTrcHisB vector – Invitrogen 
pAH191 CheA1-GFP pTrcHisB Nishiyama et al., 2016 
pDS1050 GFP fusion vector plasmid (C-terminal) pTrcHisB Hiremath et al., 2015 
pKRB101 TC-tagged CheA1 pTrcHisB Nishiyama et al., 2016 
pKRB2000 AcrB-GFP pTrcHisB Yamamoto et al., 2016 
pKRB2010 AcrD-GFP pTrcHisB Yamamoto et al., 2016 
pBAD24 vector – Guzman et al., 1995 
pKRB803 TnaA pBAD24 This study 
pKRB2050 AcrD pBAD24 Yamamoto et al., 2016 
pKRB2109 TolC pBAD24 This study 
pKRB2122 mCherry-fused TolC∆loop pBAD24 This study 
pKRB2123 TolC∆loop pBAD24 This study 
pRE1300 mCherry-fused TolC pBAD24 Tamai, 2013 
pBAD33 vector – Guzman et al., 1995 
pKRB2053 AcrD pBAD33 Yamamoto et al., 2016 
pKRB2100 TolC pBAD33 Yamamoto et al., 2016 
pKRB2104 TolC-A269C pBAD33 Yamamoto et al., 2016 
pKRB2107 TC-tagged TolC pBAD33 This study 
pTWV228 vector – Takara Bio 
pAH901 carrying FLAG-tag pTWV228 Nishiyama et al., 2012 
pMlp37 FLAG-tagged Mlp37 pTWV228 Nishiyama et al., 2016 
pKRB112 TagRFP fusion vector plasmid pTWV228 Nishiyama et al., 2016 
pKRB116 TagRFP-fused Mlp37 pTWV228 Nishiyama et al., 2016 
pKD46 λ Red recombinase – 
Datsenko & Wanner, 
2000 
pCP20 FLP recombinase – 
Datsenko & Wanner, 
2000 
pCA24N vector carrying His-tag – Kitagawa et al., 2005 
pBaeR His6-BaeR pCA24N Kitagawa et al., 2005 
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Table. VI-3. Primers used in this study. 
 
  
Products Sequence 
pKRB2000 ctagctagcatgcctaatttc 
 gaagatctatgatgatcgacag 
pKRB2010 cagttaatgtaatgcctcctac 
 caccacggtatattgtttccg 
 ctagctagcatggcgaatttc 
 gaagatctttccgggcgcggcttc 
pKRB803 ctagctagcaggaggaattcaccatggaaaactttaaacatctccctgaaccg 
 cccaagcttttaaacttctttaagttttgcggtgaagtgac 
pKRB2050 catgccatggatggcgaatttctttattgatcgcccc 
 cccaagcttttattccgggcgcggcttcag 
pKRB2109 ctagctagcaggaggaattcaccatgaagaaattgctccccattcttatcggc 
 cccaagctttcagttacggaaagggttatgaccgttac 
pKRB2122 caaaccaccggcggaggcggaatcaccgacgtgcagaacgcccgc 
 gtcggtgattccgcctccgccggtggtttgatctaattgacggtagatcgc 
pKRB2123 caaaccaccggcggaggcggaatcaccgacgtgcagaacgcccgc 
 gtcggtgattccgcctccgccggtggtttgatctaattgacggtagatcgc 
pKRB2053 cgagctcaggaggaattcacc 
 ctctcatccgccaaaac 
pKRB2100 cgagctcttgatcgcgctaaatactgcttcaccac 
 cccaagctttcagttacggaaagggttatgaccgttac 
pKRB2104 gttcgaaaacccgtggttgcgctggtacccagt 
 actgggtaccagcgcaaccacgggttttcgaac 
pKRB2107 ggtgcctgttgtcctggctgttgtgctggtacccagtatgacgatagca 
 accagcacaacagccaggacaacaggcaccacgggttttcgaaccgcta 
pKRB116 cgagctcgtgaaggaggctcgagccatgaaattcagccataaaattgttgctgcg 
 aaaactgcagacactttgaatttattcaagattgcatcctgttcg 
YKN12 gaatgaagatatcgagcacagccatactgtcgatcatcatttaagacccactttcacatt 
 aaaaaggccgcttacgcggccttagtgattacacgttgtactaagcacttgtctcctg 
 ggtggttcgccgccgctttag 
 aaaaaggccgcttacgcggccttagtgattacacgttgtattacttgtacagctcgtccatgccc 
MBRT02 gctggtgcgccgccgcttcccgctgaagccgcgcccggaattaagacccactttcacatt 
 tgaaaaaggcgacacattggcatgtcgccttttttattgcctaagcacttgtctcctg 
 tggctatttacttcgtgccgctgttc 
 tgaaaaaggcgacacattggcatgtcgccttttttattgcttacttgtacagctcgtccatgcc 
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